Max India Ltd · NSE:MAXIND
Max India — Q2 FY2020 Earnings Presentation
12 slides from Max India's earnings presentation, Nov 7, 2019
Slide 1: Max India Limited Investor Release
Max India Limited Investor Release Quarter and Half Year ended September 30, 2019 Disclaimer This release is a compilation of financial and other information all of which has not been subjected to audit and is not a statutory release. This may also contain statements that are forward looking. These
Slide 2: Max India – Key Highlights (Q2FY20)
Max India – Key Highlights (Q2FY20) Max Healthcare and Radiant to merge and list separately: Shareholders approve merger with 99.6% votes in NCLT convened meeting, NCLT approval and re-listing of Max 1 Healthcare & Advaita (New Max India) expected by Mar/Apr’20 Max Bupa divestment: Shareholder’s app
Slide 3: MHC Network (Financial Snapshot – Q2FY20)
MHC Network* (Financial Snapshot – Q2FY20) • Net revenue for Q2FY20 grows 13% to Rs. 753 Cr. • Outside NCR units gross revenue for Q2FY20 grows 19% to Rs. 118 Cr. • Alternate business gross revenue for Q2FY20 at Rs 31 Cr, grows 39% Revenue • Oncology & Renal specialities outpace overall growth, grow
Slide 4: MHC sharp improvement in EBITDA and margins
MHC has a delivered a sharp improvement in EBITDA and Margins that were temporarily hit by voluntary recalibration of business over 6 months Sharp recovery in EBITDA margins from Q1FY19, achieved all time high EBITDA margin of 15.4% in Q2FY20 * 15.4% 125 16% * 116 100 11.9% 11.6% * 13% 10.3% 75 9.7%
Slide 5: MHC Network – Performance Dashboard (Q2 & H1FY20)
MHC Network* – Performance Dashboard (Q2 & H1FY20) Rs Cr Quarter Ended Growth (%) Half Year Ended Y-o-Y Key Business Drivers Sep-19 Jun-19 Sep-18 Q-o-Q Y-o-Y Sep-19 Sep-18 Growth a) Financial Performance Revenue (Gross) 820 778 727 5% 13% 1,599 1,420 13% Revenue (Net) 753 714 664 5% 13% 1,467 1,300
Slide 6: MHC Network – Performance Dashboard (Q2 & H1FY20)
MHC Network* – Performance Dashboard (Q2 & H1FY20) Quarter Ended Growth (%) Half Year Ended Y-o-Y Key Business Drivers Sep-19 Jun-19 Sep-18 Q-o-Q Y-o-Y Sep-19 Sep-18 Growth a) Patient Transactions (Nos. in lacs) Inpatient Procedures 0.51 0.48 0.49 5% 5% 0.99 0.94 6% Day care Procedures 0.15 0.13 0.1
Slide 7: MHC Network Hospitals (Saket & East Delhi) – Performance Dashboard
MHC Network Hospitals (Saket* & East Delhi^ Complex) – Performance Dashboard (Q2 & H1FY20) Rs Cr Unit Quarter Ended Growth (%) Half Year Ended Y-o-Y Key Business Drivers Sep-19 Jun-19 Sep-18 Q-o-Q Y-o-Y Sep-19 Sep-18 Growth Saket Complex a) Financial Performance Revenue(Net) Rs. Cr 272 261 247 4% 10
Slide 8: Max Bupa (Financial Snapshot – Q2 & H1FY20)
Max Bupa (Financial Snapshot – Q2 & H1FY20) • Gross Written Premium (GWP) for Q2FY20 grows 29% to Rs. 281 Cr, driven by 50% growth in new sales and 15% growth in renewals. • Bancassurance continues to gain traction as Banca & Alliances grows 45% in Q2, contribution to GWP increases to 36% in Q2FY20
Slide 9: Max Bupa – Performance Dashboard
Max Bupa – Performance Dashboard (Q1FY20) Quarter Ended Y-o-Y Half Year Ended Y-o-Y Key Business Drivers Sep-19 Sep-18 Growth Sep-19 Sep-18 Growth a) Gross written premium income First year premium 127 85 50% 234 146 61% Renewal premium 154 134 15% 297 259 15% Total 281 219 29% 532 404 32% b) Net Ea
Slide 10: Antara next phase of growth in Noida, New Chandigarh and Assisted Living
Antara all set to pursue next phase of growth in Noida, New Chandigarh and Assisted Living via an investment light model … Antara - Dehradun Antara – Assisted Living ▪ Market size : $ 1 billion ▪ 116 apartments sold; total inventory 192 units ▪ Testing the concept by launching 2 pilots in the NCR ▪
Slide 11: Disclaimer
Disclaimer This presentation has been prepared by Max India Limited (the “Company”). No representation or warranty, express or implied, is made and no reliance should be placed on the accuracy, fairness or completeness of the information presented or contained in the presentation. The past performan
Slide 12: MAX INDIA LTD.
MAX INDIA LTD. Max House, Okhla, New Delhi – 110 020 Phone: +91 11 26933601-10 Fax: +91 11 26933619 Website: www.maxindia.com